Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-British grandma is 1st in world to get Pfizer vaccine outside trial

Tue, 08th Dec 2020 07:09

* 90-year-old grandmother gets Pfizer vaccine

* Britain rolls out COVID vaccine, first in the West

* 'I feel so privileged' says first vaccine recipient
(Adds background, details)

By Kate Holton

LONDON, Dec 8 (Reuters) - Margaret Keenan, a 90-year-old
grandmother, on Tuesday became the first person in the world to
receive the Pfizer COVID-19 vaccine shot outside of a
trial as Britain began vaccinating its population.

An early riser, Keenan received the vaccine at her local
hospital in Coventry, central England, on Tuesday morning at
0631 GMT, a week before she turns 91.

Britain began rolling out the COVID-19 vaccine developed by
Pfizer and BioNTech on Tuesday, the first Western country to
start vaccinating its general population in what was hailed as a
decisive watershed in defeating the coronavirus.

"I feel so privileged to be the first person vaccinated
against Covid-19," said Keenan.

"It's the best early birthday present I could wish for
because it means I can finally look forward to spending time
with my family and friends in the New Year after being on my own
for most of the year."

Keenan, known as Maggie to her friends, is a former
jewellery shop assistant who only retired four years ago. She
has a daughter, a son and four grandchildren.

Video footage shows her wearing a medical mask along with a
blue t-shirt and cardigan while she receives the shot from nurse
May Parsons.

Parsons said the last few months had been tough on everyone
but it felt like there was now light at the end of the tunnel.

Britain is the worst-hit European country from COVID-19,
with over 61,000 deaths, but Prime Minister Boris Johnson hopes
to turn the tide against the disease by rolling out the
Pfizer/BioNTech vaccine before the United States or European
Union.

The mass inoculation will fuel hope that the world may be
turning a corner in the fight against a pandemic that has
crushed economies and killed more than 1.5 million, although
ultra-cold storage and tricky logistics will limit its use for
now.
(Reporting by Kate Holton, editing by Estelle Shirbon/Guy
Faulconbridge)

More News
27 Dec 2023 08:48

LONDON MARKET OPEN: FTSE 100 gains led by miners and industrials

(Alliance News) - Stock prices in London opened in the green on Wednesday, as hopes for US interest rate cuts in the new year continued to propel global equities higher.

Read more
27 Dec 2023 08:26

London open: FTSE takes cues from Wall Street 'Santa rally'

(Sharecast News) - London's stocks returned from the Christmas break in the green on Wednesday, boosted by a late Santa rally on Wall Street overnight.

Read more
27 Dec 2023 08:24

TOP NEWS: AstraZeneca buys Gracell to "enrich" cell therapy pipeline

(Alliance News) - AstraZeneca PLC on Tuesday said it has agreed to acquire Gracell Biotechnologies Inc, paying about USD1.2 billion for the clinical-stage company.

Read more
27 Dec 2023 07:52

LONDON BRIEFING: AstraZeneca buys Gracell Biotech; COPL CEO resigns

(Alliance News) - Stocks in London were expected to make gains at Wednesday's market open, as investors continued to pin their hopes on US interest rate cuts.

Read more
27 Dec 2023 07:02

AstraZeneca to buy Gracell Technologies for $1.2bn

(Sharecast News) - AstraZeneca on Wednesday said it was buying Gracell Biotechnologies, a global clinical-stage biopharmaceutical company developing cell therapies for the treatment of cancer and autoimmune diseases, for $1.2bn.

Read more
26 Dec 2023 21:26

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 21:00

Wall Street ends higher in final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
26 Dec 2023 19:41

Wall Street gains on final stretch of 2023, rate cuts in view

Intel up on $3.2 bln grant from Israel

*

Read more
22 Dec 2023 08:47

AstraZeneca, Ionis get US FDA nod for Wainua in "important milestone"

(Alliance News) - AstraZeneca PLC and Ionis Pharmaceuticals Inc on Friday celebrated the news that their drug eplontersen was approved by the US Food & Drug Administration.

Read more
22 Dec 2023 07:50

LONDON BRIEFING: UK on brink of recession as economy contracts in Q3

(Alliance News) - Stocks in London are likely to open lower on Friday, with investors feeling frosty ahead of a US inflation print this afternoon, amid sobering UK economic growth data.

Read more
22 Dec 2023 07:17

AstraZeneca gets FDA green light for nerve disease treatment

(Sharecast News) - The US Food and Drug Administration has approved the Wainua nerve disease treatment jointly developed by AstraZeneca and Ionis Pharmaceuticals.

Read more
19 Dec 2023 19:56

US adds 13 companies in China to Unverified List

WASHINGTON, Dec 19 (Reuters) - The United States has added 13 companies in China to a list of entities receiving U.S. exports that officials have been unable to inspect, according to a government notice posted on Tuesday.

Read more
15 Dec 2023 17:14

London stocks log weekly gains as cenbank fest ends

FTSE 100 down 1.0%, FTSE 250 off -0.3%

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.